Activin A Inhibits MPTP and LPS-Induced Increases in Inflammatory Cell Populations and Loss of Dopamine Neurons in the Mouse Midbrain In Vivo.
Parkinson's disease is a chronic neurodegenerative disease characterized by a significant loss of dopaminergic neurons within the substantia nigra pars compacta region and a subsequent loss of dopamine within the striatum. A promising avenue of research has been the administration of growth fac...
Main Authors: | Sandy Stayte, Peggy Rentsch, Anna R Tröscher, Maximilian Bamberger, Kong M Li, Bryce Vissel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5266209?pdf=render |
Similar Items
-
Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on l-Dopa induced dyskinesia
by: Peggy Rentsch, et al.
Published: (2019-02-01) -
Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia
by: Peggy Rentsch, et al.
Published: (2020-02-01) -
Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson’s disease
by: Sandy eStayte, et al.
Published: (2014-08-01) -
Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
by: Sandy eStayte, et al.
Published: (2014-05-01) -
Reliability in the identification of midbrain dopamine neurons.
by: Elyssa B Margolis, et al.
Published: (2010-01-01)